(Q28294477)

https://api.crossref.org/works/10.1038%2FNRI2062

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Mechanistic insight into osteoclast differentiation in osteoimmunology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoimmunology: interplay between the immune system and bone metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Bone versus immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoclasts, rheumatoid arthritis, and osteoimmunology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Inflammatory bone destruction and osteoimmunology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The molecular understanding of osteoclast differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

RANK-L and RANK: T cells, bone loss, and mammalian evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoblastic cells regulate the haematopoietic stem cell niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Identification of the haematopoietic stem cell niche and control of the niche size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Anti-TNF-alpha therapies: the next generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Bone quality--the material and structural basis of bone strength and fragility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Control of osteoblast function and regulation of bone mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Reaching a genetic and molecular understanding of skeletal development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoclast differentiation and activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Genetic regulation of osteoclast development and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Regulation of cancer cell migration and bone metastasis by RANKL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Strength of TRAF6 signalling determines osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Requirement for NF-kappaB in osteoclast and B-cell development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Ubiquitin signalling in the NF-kappaB pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Toll-like receptor signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Fos/AP-1 proteins in bone and the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

NFAT signaling: choreographing the social lives of cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Transcriptional regulation by calcium, calcineurin, and NFAT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Interplay between interferon and other cytokine systems in bone metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Role of nuclear factor-kappaB in the immune system and bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

c-Fos suppresses systemic inflammatory response to endotoxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

NFATc1 and NFATc2 together control both T and B cell activation and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

NFAT and Osterix cooperatively regulate bone formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Calcineurin regulates bone formation by the osteoblast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Calcineurin/NFAT signaling in osteoblasts regulates bone mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Stat1-mediated cytoplasmic attenuation in osteoimmunology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast forma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

A novel member of the leukocyte receptor complex regulates osteoclast differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

RANKL-induced DC-STAMP is essential for osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Role of ITAM-containing adapter proteins and their receptors in the immune system and bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Osteoclasts are essential for TNF-alpha-mediated joint destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Activated T lymphocytes support osteoclast formation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Postmenopausal osteoporosis, T cells, and immune dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Wnt signaling in the stem cell niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Cellular niches controlling B lymphocyte behavior within bone marrow during development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Denosumab in postmenopausal women with low bone mineral density

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062

Interleukin 6: from bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI2062